These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
105 related articles for article (PubMed ID: 7242068)
1. Myocardial recovery: perfusion of the fibrillating heart versus cold chemical cardioplegia. Kay HR; Barash PG; Hammond G; Geha A; Kopriva CJ; Laks H J Surg Res; 1981 May; 30(5):515-21. PubMed ID: 7242068 [No Abstract] [Full Text] [Related]
2. The role of local disparity in conduction and recovery time on ventricular vulnerability to fibrillation. Merx W; Yoon MS; Han J Am Heart J; 1977 Nov; 94(5):603-10. PubMed ID: 910699 [No Abstract] [Full Text] [Related]
3. [Myocardial metabolism during coronary perfusion at 10 degrees C with or without cardioplegia associated with potassium]. Mikaeloff P; Amouroux C; Boivin J; Guidollet J; Vial C; El Kirat M Arch Mal Coeur Vaiss; 1980 Sep; 73(9):1075-85. PubMed ID: 6776926 [TBL] [Abstract][Full Text] [Related]
4. All-blood (miniplegia) versus dilute cardioplegia in experimental surgical revascularization of evolving infarction. Velez DA; Morris CD; Budde JM; Muraki S; Otto RN; Guyton RA; Vinten-Johansen J Circulation; 2001 Sep; 104(12 Suppl 1):I296-302. PubMed ID: 11568072 [TBL] [Abstract][Full Text] [Related]
5. [Cardiosynchronized perfusion of the coronary sinus as a method of myocardial revascularization]. Shumakov VI; Tollekin VE; Tsepelev VN; Meluzov KL; Amosov GG Kardiologiia; 1980 Oct; 20(10):86-8. PubMed ID: 7441966 [TBL] [Abstract][Full Text] [Related]
6. [Comparative study of myocardial protection by coronary perfusion in deep hypothermia (10 degrees C) with or without potassium cardioplegia. Clinical, electrocardiographic, enzymatic results; biochemical and histological controls]. Mikaeloff P; Amouroux C; Boivin J; Loire R; Vial C; Guidollet G; Font B; Goldschmidt D; Van Haecke P; Bouillot A Arch Mal Coeur Vaiss; 1980 Jun; 73(6):701-12. PubMed ID: 6779764 [TBL] [Abstract][Full Text] [Related]
10. Energetics of the fibrillating ventricle. Yaku H; Goto Y; Futaki S; Ohgoshi Y; Kawaguchi O; Hata K; Takasago T; Suga H Front Med Biol Eng; 1992; 4(2):87-93. PubMed ID: 1510888 [TBL] [Abstract][Full Text] [Related]
11. Effect of myocardial revascularization on ventricular fibrillation thresholds in dogs. Kass TG; Symes JF; Chiu CJ; Blundell PE Can J Surg; 1974 Mar; 17(2):97-101. PubMed ID: 4817698 [No Abstract] [Full Text] [Related]
12. Relative effect of chronic ischemia and a myocardial revascularization procedure on the ventricular fibrillation threshold. MACLEAN LD; PHIBBS CM Circ Res; 1960 Mar; 8():473-8. PubMed ID: 14419576 [No Abstract] [Full Text] [Related]
14. Inadequate ischaemia-selectivity limits the antiarrhythmic efficacy of mibefradil during regional ischaemia and reperfusion in the rat isolated perfused heart. Farkas A; Qureshi A; Curtis MJ Br J Pharmacol; 1999 Sep; 128(1):41-50. PubMed ID: 10498833 [TBL] [Abstract][Full Text] [Related]
15. Effects of perfusion pressure on myocardial performance, metabolism, wall thickness, and compliance: comparison of the beating and fibrillating heart. Spadaro J; Bing OH; Gaasch WH; Laraia P; Franklin A; Weintraub RM J Thorac Cardiovasc Surg; 1982 Sep; 84(3):398-405. PubMed ID: 7109670 [TBL] [Abstract][Full Text] [Related]
16. Coronary arteriotomy with cardioplegia. Kirsh MM; Sloan H Ann Thorac Surg; 1979 May; 27(5):478. PubMed ID: 454024 [No Abstract] [Full Text] [Related]